Initial illness severity assessment

Guideline | Guideline Working Group Members | Grade recommendation strength and evidence quality definitions | Diagnosis | Risk factors for severe illness | SARS-CoV-2 co-infection | Initial illness severity assessment | Investigations | Monitoring | Respiratory support | Evidence-based approach to the use of respiratory support | Medication | Chest physiotherapy | Hydration/ nutrition | Safety initiatives | Discharge-planning and community-based management | Criteria for safe discharge | Prevention of RSV bronchiolitis | Summary of key changes in the recommendations between the 2016 guideline and 2025 update | 2016 guideline | Endorsements | Manuscripts | Education Modules

Initial Illness severity assessment

1 Note, early warning scores have been developed and validated for use in inpatient settings and not in EDs. SpO2= Peripheral oxygen saturation. This table is meant to provide guidance in order to stratify. The more symptoms the infant has in the moderate to severe categories, the more likely they are to have moderate or severe disease.

Throughout the guideline, the terms mild, moderate, and severe are used with regards to the clinical condition of the infant with bronchiolitis. Within the research literature, the definition of these subgroups varies. Further, the definition of these terms varies between individual clinicians and healthcare settings. The evidence for bronchiolitis diagnosis and management is largely based on observational studies or RCTs which have occurred in the ED, inpatient paediatric wards, or in the ICU. 

To define mild, moderate, and severe disease, a pragmatic definition has been developed that is consistent with the inclusion and exclusion criteria from the majority of the evidence (Table 2). This table is intended to serve as a reference point to help define and guide assessments of illness severity. It may also be used to clarify definitions of mild, moderate, and severe bronchiolitis used in the guideline recommendations.What level of care is required for infants with bronchiolitis?

Within Australia and Aotearoa New Zealand, management of bronchiolitis is such, that while tertiary children’s hospitals may see patients who move through the various levels of care from ED to inpatient ward to ICU based on the settings that the studies have occurred in, this may not be reflective of care in metropolitan, regional, and rural hospitals, where most infants with bronchiolitis are seen. In these hospitals, bronchiolitis patients with severe disease may be managed for some time in an ED or inpatient paediatric ward prior to transfer to a tertiary children’s hospital ICU or managed in an adult ICU without transfer. Transfer should occur safely according to local protocols.

The appropriate setting for delivery of care should reflect resources and skills that are available, rather than a specific physical location or label. 

• Standard nursing ratios in the ED and ward environment are suitable for infants with mild or moderate bronchiolitis (Table 2).
  • For mild disease, no hydration or respiratory support is required, and these infants are usually managed in ED and as an outpatient.
  • For moderate disease, hydration support and/or oxygen therapy (low flow or HF oxygen) can be safely delivered in an ED or ward environment with standard nursing ratios.
• Standard nursing ratios in the ED and ward environment have been shown to be safe for stable infants on HF therapy.

Severe bronchiolitis (Table 2) requires either a 1:1 or 1:2 nursing ratio. This will usually require HDU/ICU care, or escalation to a higher level of care depending on the health facility, and may involve transport to an HDU/ICU or higher-level facility. Post stabilisation of severe bronchiolitis with improvement in condition, nursing ratios can be revised.